STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Viatris to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Viatris (Nasdaq: VTRS) will participate in two investor events in November 2025. The company will appear in a fireside chat at the UBS Global Healthcare Conference on November 11, 2025 at 8:45 a.m. ET, and in a fireside chat at the Jefferies Global Healthcare Conference in London on November 18, 2025 at 11:30 a.m. GMT / 6:30 a.m. ET. Investors and the public can listen live and access archived sessions at investor.viatris.com for a limited time after each event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

PITTSBURGH, Oct. 13, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in November 2025.

The Company will participate in a fireside chat at the UBS Global Healthcare Conference 2025 on November 11, 2025, at 8:45 a.m. ET.

In addition, the Company will take part in a fireside chat at the Jefferies Global Healthcare Conference in London on November 18, 2025, at 11:30 a.m. GMT / 6:30 a.m. ET.

Investors and the general public are invited to listen to both sessions at their respective times at investor.viatris.com. An archived version of each session will be available following the live event and can be accessed at the same location for a limited time.

About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-upcoming-investor-conferences-302581460.html

SOURCE Viatris Inc.

FAQ

When will Viatris (VTRS) present at the UBS Global Healthcare Conference in 2025?

Viatris will present at the UBS Global Healthcare Conference on November 11, 2025 at 8:45 a.m. ET.

What time is Viatris (VTRS) scheduled for the Jefferies Global Healthcare Conference in London?

The Jefferies session is scheduled for November 18, 2025 at 11:30 a.m. GMT / 6:30 a.m. ET.

How can investors listen to Viatris (VTRS) fireside chats in November 2025?

Both sessions will be available live and as archived recordings at investor.viatris.com.

Will Viatris (VTRS) make archived recordings of the November 2025 presentations available?

Yes. Archived versions of each session will be available for a limited time at investor.viatris.com after the live events.

Are Viatris (VTRS) investor events in November 2025 open to the public?

Yes. Investors and the general public are invited to listen to the live sessions at the scheduled times via investor.viatris.com.

Which conferences will Viatris (VTRS) attend in November 2025?

Viatris will participate in the UBS Global Healthcare Conference on November 11 and the Jefferies Global Healthcare Conference in London on November 18, 2025.
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

12.25B
1.15B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG